[go: up one dir, main page]

SE8702550D0 - Cysteinproteashemmare - Google Patents

Cysteinproteashemmare

Info

Publication number
SE8702550D0
SE8702550D0 SE8702550A SE8702550A SE8702550D0 SE 8702550 D0 SE8702550 D0 SE 8702550D0 SE 8702550 A SE8702550 A SE 8702550A SE 8702550 A SE8702550 A SE 8702550A SE 8702550 D0 SE8702550 D0 SE 8702550D0
Authority
SE
Sweden
Prior art keywords
gly
pro
val
pct
leu
Prior art date
Application number
SE8702550A
Other languages
English (en)
Inventor
Anders Grubb
Magnus Abrahamson
Jerzy Trojnar
Original Assignee
Anders Grubb
Magnus Abrahamson
Jerzy Trojnar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anders Grubb, Magnus Abrahamson, Jerzy Trojnar filed Critical Anders Grubb
Priority to SE8702550A priority Critical patent/SE8702550D0/sv
Publication of SE8702550D0 publication Critical patent/SE8702550D0/sv
Priority to EP88906175A priority patent/EP0418233A1/en
Priority to PCT/SE1988/000334 priority patent/WO1988010266A1/en
Priority to JP63505269A priority patent/JPH02503917A/ja
Priority to US07/435,463 priority patent/US5037957A/en
Priority to AU19604/88A priority patent/AU604944B2/en
Priority to FI896029A priority patent/FI896029A7/sv
Priority to NO895008A priority patent/NO895008D0/no
Priority to DK637489A priority patent/DK637489A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SE8702550A 1987-06-18 1987-06-18 Cysteinproteashemmare SE8702550D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE8702550A SE8702550D0 (sv) 1987-06-18 1987-06-18 Cysteinproteashemmare
EP88906175A EP0418233A1 (en) 1987-06-18 1988-06-17 Cysteine proteinase inhibitor
PCT/SE1988/000334 WO1988010266A1 (en) 1987-06-18 1988-06-17 Cysteine proteinase inhibitor
JP63505269A JPH02503917A (ja) 1987-06-18 1988-06-17 システインプロテイナーゼ阻害剤
US07/435,463 US5037957A (en) 1987-06-18 1988-06-17 Cysteine proteinase inhibitor
AU19604/88A AU604944B2 (en) 1987-06-18 1988-06-17 Cysteine proteinase inhibitor
FI896029A FI896029A7 (sv) 1987-06-18 1988-06-17 Cysteinproteinas-inhibitor
NO895008A NO895008D0 (no) 1987-06-18 1989-12-13 Cysteinproteasehemmer.
DK637489A DK637489A (da) 1987-06-18 1989-12-15 Cysteinproteinaseinhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8702550A SE8702550D0 (sv) 1987-06-18 1987-06-18 Cysteinproteashemmare

Publications (1)

Publication Number Publication Date
SE8702550D0 true SE8702550D0 (sv) 1987-06-18

Family

ID=20368906

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8702550A SE8702550D0 (sv) 1987-06-18 1987-06-18 Cysteinproteashemmare

Country Status (7)

Country Link
US (1) US5037957A (sv)
EP (1) EP0418233A1 (sv)
JP (1) JPH02503917A (sv)
AU (1) AU604944B2 (sv)
FI (1) FI896029A7 (sv)
SE (1) SE8702550D0 (sv)
WO (1) WO1988010266A1 (sv)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189144A (en) * 1989-04-28 1993-02-23 Takara Shuzo Co., Ltd. Human calpastatin-like polypeptide
US5444042A (en) * 1990-12-28 1995-08-22 Cortex Pharmaceuticals Method of treatment of neurodegeneration with calpain inhibitors
US5472945A (en) * 1991-08-13 1995-12-05 Temple University- Of The Commonwealth System Of Higher Education Modulation of blood pressure and inhibition of platelet activation with kininogen fragment
IL112759A0 (en) 1994-02-25 1995-05-26 Khepri Pharmaceuticals Inc Novel cysteine protease inhibitors
US5693617A (en) * 1994-03-15 1997-12-02 Proscript, Inc. Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
US6660268B1 (en) 1994-03-18 2003-12-09 The President And Fellows Of Harvard College Proteasome regulation of NF-KB activity
DE69531103T2 (de) * 1994-04-19 2004-05-19 Kanebo, Ltd. Für kreislauferkrankungen vorbeugendes mittel
US6083903A (en) * 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
US5905076A (en) * 1996-04-10 1999-05-18 National Research Council Of Canada 6-substituted amino-4-oxa-1-azabicyclo 3,2,0! heptan-7-one derivatives as cysteine protease inhibitors
CA2319195A1 (en) 1998-02-02 1999-08-05 Trustees Of Tufts College Method of regulating glucose metabolism, and reagents related thereto
US6514941B1 (en) 1999-12-10 2003-02-04 Campina Melkunie B.V. Method of preparing a casein hydrolysate enriched in anti-hypertensive peptides
JP2005511636A (ja) 2001-11-26 2005-04-28 トラスティーズ オブ タフツ カレッジ 自己免疫疾患の治療方法及びそれに関する試薬
EA006860B1 (ru) * 2002-01-29 2006-04-28 Уайт Композиции и способы модулирования гемиканалов коннексина
ES2421516T3 (es) 2002-11-06 2013-09-03 Dana Farber Cancer Inst Inc Composiciones para tratar el cáncer usando el inhibidor de proteasomas PS-341
JP2009510131A (ja) 2005-10-07 2009-03-12 バイオファルミカ リミテッド Ｓｕｍｏ化制御剤及びその用途
AU2007236546B2 (en) 2006-04-07 2013-02-21 Molecular Discovery Systems Transcription factor modulator
US9895449B2 (en) 2010-05-25 2018-02-20 Syndevrx, Inc. Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
EP2576638B1 (en) 2010-05-25 2020-12-23 Syndevrx, Inc. Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereof
BR112015025892A2 (pt) * 2013-04-10 2017-07-25 Syndevrx Inc inibidores de metap2 e métodos para tratar obesidade
DK3386956T3 (da) 2015-12-10 2021-10-11 Syndevrx Inc Fumagillolderivater og polymorfer deraf
WO2017118726A1 (en) 2016-01-06 2017-07-13 Lonza Ltd Inhibition of protein degradation for improved production
CA3239447A1 (en) 2016-01-11 2017-07-20 Syndevrx, Inc. Treatment for tumors driven by metabolic dysfunction
RU2020134124A (ru) 2018-03-20 2022-04-20 АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи СПОСОБЫ ЛЕЧЕНИЯ НАРУШЕНИЙ ЦЕНТРАЛЬНОЙ НЕРВНОЙ СИСТЕМЫ ПУТЕМ ВВЕДЕНИЯ СОДЕРЖАЩИХ ИНГИБИТОР mTOR И АЛЬБУМИН НАНОЧАСТИЦ
CA3117666A1 (en) 2018-10-26 2020-04-30 Syndevrx, Inc. Biomarkers of metap2 inhibitors and applications thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100117A (en) * 1977-04-21 1978-07-11 Eli Lilly And Company Somatostatin analogs and intermediates thereto

Also Published As

Publication number Publication date
AU1960488A (en) 1989-01-19
FI896029A0 (fi) 1989-12-15
EP0418233A1 (en) 1991-03-27
AU604944B2 (en) 1991-01-03
US5037957A (en) 1991-08-06
WO1988010266A1 (en) 1988-12-29
JPH02503917A (ja) 1990-11-15
FI896029A7 (sv) 1989-12-15

Similar Documents

Publication Publication Date Title
SE8702550D0 (sv) Cysteinproteashemmare
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
BR0012243A (pt) Triflúor butenos nematocidas
ITMI912457A1 (it) Policarbonati dioloterminati
IS4166A (is) Aðferð til að framleiða nýjar peptíðafleiður sem eru þrombíntálmar
ES555826A0 (es) Procedimiento para preparar peptidos difluorcetonicos
DK1489097T3 (da) Hæmmere af humant plasmin, der er afledt af kunitz-domæner, og nukleinsyrer, der koder for samme
DK1263471T3 (da) Antimikrobielle forbindelser og formuleringer
BG38487A3 (en) Method for preparing peptides
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
NO303783B1 (no) Substituerte aminofosfonatderivater og farmas°ytiske preparater derav
JPS56156289A (en) Metal chelate of 1,4-bis(substituted amino)- 5,8-dihydroxyanthraquinone
SE9101838D0 (sv) Novel peptides and their use
ATE121754T1 (de) Vakzine gegen bordetella.
DK0463053T3 (da) Fremstilling og anvendelse af anthelmintiske midler og beskyttende immunogener
CA2188176A1 (fr) (oxo-1 alkyl) amino-2, deoxy-2 glucopyranoside de dihydroxy - 2,3 propyl, leur procede de preparation et leurs utilisations
DK0548177T3 (da) 5-Aminosalicylsyrederivater til terapi af kroniske inflammatoriske tarmsygdomme
NZ228023A (en) 24(r)-scymnol; preparatory processes and pharmaceutical compositions
AU542310B2 (en) Glicentin related purified peptide having 30 amino acids
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
IT8120307A0 (it) Disposizione per il trattamento termico di pezzi d'opera.
NO910664L (no) Fremgangsmaate ved fremstilling av lh-rh-analoger med temporaer og minimal beskyttelse.
IT1263959B (it) N-acil-peptidi inibitori delle protein-chinasi